Compare FROG & RDNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FROG | RDNT |
|---|---|---|
| Founded | 2008 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 6.4B |
| IPO Year | 2020 | 1986 |
| Metric | FROG | RDNT |
|---|---|---|
| Price | $69.30 | $74.80 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 18 | 5 |
| Target Price | $62.39 | ★ $83.60 |
| AVG Volume (30 Days) | ★ 1.9M | 811.1K |
| Earning Date | 11-06-2025 | 11-09-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $502,612,000.00 | ★ $1,969,599,000.00 |
| Revenue This Year | $24.89 | $11.77 |
| Revenue Next Year | $16.63 | $10.76 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 22.69 | 11.09 |
| 52 Week Low | $27.00 | $45.00 |
| 52 Week High | $70.43 | $85.84 |
| Indicator | FROG | RDNT |
|---|---|---|
| Relative Strength Index (RSI) | 70.71 | 40.41 |
| Support Level | $59.27 | $74.96 |
| Resistance Level | $70.43 | $81.35 |
| Average True Range (ATR) | 2.61 | 2.89 |
| MACD | 0.42 | -0.68 |
| Stochastic Oscillator | 85.84 | 2.90 |
JFrog Ltd provides an end-to-end, hybrid, universal DevOps Platform that powers and controls the software supply chain, enabling organizations to continuously and securely deliver software updates across any system. Its product portfolio includes JFrog Artifactory; JFrog Pipelines; JFrog Xray; JFrog Distribution; JFrog Artifactory Edge; JFrog Mission Control and JFrog Insight. Geographically, it derives a majority of revenue from Israel and also has its presence in United States, India and other regions.
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics.